InvestorsHub Logo
icon url

happyglass

03/06/20 7:33 PM

#2277 RE: DropLine #2276

There was an excellent interview with Kiran Sidhu from Halo labs on Rich tv live today. He has some very interesting insights to the industry and how it is playing out. He mentions how his strategy has changed over time as the US cannabis industry has matured. This might be of interest to you folks here. I find him very genuine in his observations. I really like the extraction space but it was interesting to hear him say they had to diversify and stay nimble.
icon url

happyglass

03/06/20 7:49 PM

#2278 RE: DropLine #2276

Thank you for the links! Fool has good info sometimes, I like to hear what they are saying but if I had listened to their advice in 2015 I would not have made as much on Canopy. The points they make are valid but I see the traffic at the Choom store here in Niagara Falls. The Ontario govt is opening more stores and the Choom shop I go to is the first of the chain to open and they are now up to 6 or 7 more across Canada with an eye for the US when possible or they would not have named it after the Hawaiian “Choom” gang of which Obama was a member. Vapes and edibles fly at that shop and I am sure Valens has a piece of a whole bunch of those products.
icon url

LoveAndLight

03/06/20 10:39 PM

#2280 RE: DropLine #2276

Okay DropLine, This message board is specifically for Valens Company VLNCF investors, and not a broad cannabis market board. Let's make that clear first off! Those two articles from fool.com you posted are somewhat old already and are about the broad cannabis market concerns but they make no mention of how great the Valens Company is doing compared to the rest of the cannabis market. And one of the things they talked about was the illicit black market still being a future threat in competing sales against the new 2.0 legal cannabis products marketplace. I couldn't disagree with that synopsis more. In fact, the legal market is going to be much more safer, credible and consistent to cannabis customers and consumers. I would say the future of the black market should be more worried now about dramatically losing sales and staying in business than the other way around. But who cares about what happens to the black market really? :-)

And I guess you haven't seen and read the most recent articles on fool.com the past couple of days saying nothing but great things about The Valens Company?... In fact, from what I've seen and been reading... there's been nothing but good press and reviews about Valens across all media news reporting outlets and analyst platforms. I challenge you to find one who does say anything bad about Valens! :-)

Now read these articles and let's talk about all the good things going on with Valens shall we? :-)

Here ya go...
Article #1...

5 Marijuana Stocks That Can Make Money During a Recession
These pot stocks can deliver the green in any economic environment.
The Motley Fool on fool.com...
Mar 5, 2020 at 7:21AM

https://www.fool.com/investing/2020/03/05/5-marijuana-stocks-that-can-make-money-during-a-re.aspx

There are a few companies within one of the fastest growing industries on the planet -- marijuana -- that should fare just fine if a North American or global recession ensues. If things continue to grow bleaker, economically, look for these five marijuana stocks to make money.

Valens
Extraction-services provider Valens (OTC:VLNCF) is another company with a very good chance of generating recurring profits, even if a recession were to strike.

Based in Canada, Valens sits at the center of one of the fastest-growing trends within the marijuana industry: derivatives. Derivatives being alternative consumption options, such as edibles, infused beverages, vapes, topicals, and concentrates. Derivatives offer considerably juicier margins than traditional dried flower, making them a must-have for every grower's product portfolio. And derivatives can't be made without first processing hemp or cannabis biomass, which is what Valens does for a living.

Last week, Valens wound up reporting its fourth-quarter and full-year operating results. Despite only commencing processing operations a little more than a year ago, Valens' revenue grew by 86% from the sequential third quarter to $30.6 million, with adjusted EBITDA of $17.7 million. Though the company officially lost money on a full-year basis, Valens earned $8.3 million on an operating basis. Given that derivatives are finally coming into their own in Canada, this operating income should expand further in 2020 and beyond. :-)



Article #2...

This Canadian Marijuana Stock Is Running Circles Around Aurora Cannabis and Canopy Growth
Faster revenue growth. Profitability. Better stock performance. This under-the-radar Canadian cannabis company is trouncing the big players.

The Motley Fool on fool.com...
Mar 4, 2020 at 7:02AM

https://www.fool.com/investing/2020/03/04/this-canadian-marijuana-stock-is-running-circles-a.aspx

There's a small Canadian company that's absolutely running circles around Aurora and Canopy. Not only is its stock handily outperforming both of the bigger cannabis producers' stocks, but it has also delivered much more impressive financial results. I think that Valens (OTC:VLNCF) just might be the best Canadian marijuana stock of all.

Neither Canopy nor Aurora holds a candle to Valens. Last week, Valens announced that its revenue in Q4 soared 86% quarter over quarter to 30.6 million in Canadian dollars. This figure was better than high end of the company's guidance.

The Cannabis 2.0 market in Canada is just getting started after its launch in December 2019. Valens is poised to profit from its contracts with major players such as Canopy Growth and even more from its white-label deals with customers including BRNT, Shoppers Drug Mart, and Iconic Brewing.

Valens is also looking to grow outside of Canada. The company expects to soon begin shipping white-labeled cannabis tincture products to Australia. It has an exclusive license to distribute cannabis-infused products in Australia, Europe, and Mexico using SoRSE emulsion technology.

Aurora is crawling. Canopy is walking. But right now it's Valens that's running -- and running circles around these bigger marijuana stocks. :-)



Blessings and best wishes,
LoveAndLight :-)
icon url

DropLine

03/09/20 12:38 PM

#2306 RE: DropLine #2276

Good information pertainig to a few companies $VLNCF does business with...

March 9, 2020 12:25 PM ET (BZ Newswire) -- Cannabis
To get into the feel of the new week, here are the top cannabis news from the last seven days.
Illinois said it sold roughly $35 million in legal cannabis over the month of February, its second month of adult use sales. This compared to $40 million in January.
The U.K. relaxed its rules for the import of medical marijuana and derivate products, promising “[p]atients prescribed cannabis-based medicines will be able to get their treatment in days rather than months.”
In Mexico, three Senate commissions passed a bill to legalize cannabis for all of its uses in a coordinated effort. The legislation will now be subject to vote in the full Senate. If approved it will move to the last instance: the lower legislative chamber.
The World Health Organization, which supposed to hold a vote on cannabis scheduling, decided to postpone the decision until December. Alfredo Pascual of MJBizDaily, who keeps a close eye on all international developments, explained “The delay underscores the difficulty in reaching agreements on cannabis policy on a level that transcends national borders.” In his view, “Given the current level of disagreement, postponing the vote was the best outcome for the recommendations to stand any chance of approval.”
Back in the U.S., South by Southwest, which was offering a cannabusiness track again this year, was cancelled due to concerns over COVID-19.
"While the corona virus has had an impact on the cannabis industry with some conferences choosing to cancel, it seems the vape industry is back online," Debra Borchard, CEO of Green Market Report, told Benzinga. "TILT Holdings said its Chinese manufacturers are sending employees back to work. Production was certainly slowed or completely halted, but the added bonus was that excess vape inventory was worked down."


In the markets front, there was a plethora of news from Canopy Growth Corp (NYSE:CGC), which announced an agreement with UNIVO Pharmaceuticals (TASE: UNVO) where the latter will import Canopy medical cannabis, and use it to manufacture its own products. During the second stage of the agreement, Canopy will obtain the right to sign an agreement with Univo as manufacturer and distributor of medical cannabis products in the European Union.
BioSteel, a company that’s majority-owned by Canopy, announced it started selling its new line of BioSteel CBD for Sport products at all Vitamin Shoppe locations across the U.S. And Houseplant, the Canadian cannabis company co-founded by Seth Rogen and Evan Goldberg, in partnership with Canopy, officially launched in the Alberta market in Canada.

On the other hand, the Canadian behemoth came out with news about the closing of its facilities in Aldergrove and Delta, British Columbia. This move resulted in the termination of around 500 employees, the company said, adding it has also dropped its plan to open a third greenhouse online in Niagara-on-the-Lake, Ontario. Interestingly enough, analysts backed the move.

Field Trip Health, a wholly owned subsidiary of Field Trip Psychedelics, a mental wellness company focused on psychedelics and psychedelic-enhanced psychotherapy, debuted its first medical center in Toronto on Wednesday. The center will be dedicated exclusively to the administration of psychedelic-enhanced psychotherapy. The clinic intends to provide an alternative to people seeking mental health treatment, in a context where many finde current pharmacologic options (like antidepressants) pretty ineffective.

Neuro-pharmaceutical company Mind Medicine Inc. (OTC:MMEDF)(NEO:MMED) made its public market debut on the Canadian NEO Exchange, under the symbol "MMED.” The exchange's approval of MindMed makes it the first psychedelic company to be publicly listed, according to NEO's press release.
Investors, executives and thought leaders recently converged at the Fontainebleau Miami Beach resort to network and exchange visions for the cannabis industry during the Benzinga Cannabis Capital Conference. NBC’s "Today Show" visited the conference as part of a feature on rising cannabis use among baby boomers — specifically women and older, more educated, higher-income Americans.

All major ETFs, the Horizons Marijuana Life Sciences Index ETF (OTC:HMLSF) (TSE:HMMJ), the ETFMG Alternative Harvest ETF (NYSE:MJ), the AdvisorShares Pure Cannabis ETF (NYSE:YOLO), the Cannabis ETF (NYSE:THCX), and the Amplify Seymour Cannabis ETF (NYSE:CNBS), were all down, along with the markets.

More News From The Week
Seeking to address the confusion around terpenes the American Trade Association of Cannabis and Hemp (ATACH), Boveda, and other industry organizations created an alliance called SaveTheTerps.org. SaveTheTerps.org was founded to help people understand the many benefits of terpenes and the importance of preserving them. To support this mission, SaveTheTerps.org is creating educational content for consumers and programs for cannabis companies to demonstrate their commitment to protecting the quality and integrity of their products.
“Even as the cannabis industry becomes increasingly destigmatized, terpenes are not well understood," Sean Knutsen, President and CEO of Boveda, told Benzinga. "Terpenes are critical to the experience and efficacy of cannabis, and we want everyone to understand the value of protecting them from damage and evaporation. Boveda founded SaveTheTerps.org to empower consumers to make informed choices about the quality of their flower.”
Curaleaf Holdings Inc (OTC:CURLF) released its Ground Flower Pod Refills in New York. The refills allow the Ground Flower Pods, or vape devices, to be filled with the amount of cannabis needed without consuming the whole pod through a single vaporization. Each of Curaleaf’s Ground Flower Refills contain 3.5g of premium cured cannabis and 700mg of major cannabinoids in the THC:CBD ratio of 20:1.
“Curaleaf is excited to continue to bring medical cannabis flower products, the most affordable form of cannabis, to our patients in New York," said Olga Krueger, President of Curaleaf New York. "Offering patients more diverse and affordable products and professional, compassionate guidance is the best way to encourage participation in the regulated, legal market for medical cannabis.”
The company also sait it will purchase BlueKudu, a manufacturer of cannabis chocolates and gummies in Colorado.
Cresco Labs Inc. (OTC:CRLBF) (CSE:CL) President Joe Caltabiano resigned from his spot. Caltabiano’s duties will be handed over to CEO and co-founder Charlie Bachtell and other members of the company’s leadership team, according to Cresco.
Green Organic Dutchman Holdings Ltd (OTC:TGODF) announced an educational program that will help Canadians and budtenders get the information they need when shopping for cannabis products.
“Launching this Organic Certification initiative that clearly and reliably communicates our differentiated offer of clean products through our certified organic cannabis creates a great opportunity for TGOD," said Drew Campbell, Vice President of Marketing at TGOD. "Further to that, working with a group like FUSE that can scale a program from coast to coast ensures that budtenders receive a consistent message everywhere. Budtenders are thirsty for information and being able to tell our remarkable, unique story of certified organic growing while giving them more tools to engage/educate their growing volume of Canadian consumers is a win:win:win.”   
Front Range Biosciences, an agricultural technology company that specializes in tissue culture propagation and breeding of high-value crops, launched hemp and coffee plant cell cultures to space from the Kennedy Space Center. FRB partnered with SpaceCells USA Inc. and BioServe Space Technologies at the University of Colorado Boulder to examine the effects of zero gravity on plant gene expressions.
The 480 tissue cultures — stored in space-made Plate Habitats (PHabs) — will take off via the SpaceX CRS-20 cargo flight and will be delivered to the International Space Station (ISS). After a 31 day incubation and observation period, the PHabs will be transferred to the SpaceX Dragon capsule to return to Earth for further evaluation. 
Tilray, Inc. (NASDAQ:TLRY) reported fourth-quarter losses at $2.14 per share, which does not compare to the 35-cent loss estimate. The company saw sales $46.936 million, missing analyst estimates of $55.92 million. Tilray also reported fourth-quarter total cannabis kilogram equivalents sold 15.039K kg and adjusted EBITDA loss of $35.3 million. Shares traded down following the results.
PharmaCielo Ltd (OTC:PCLOF) plunged after short seller Hindenburg Research released a report alleging PharmaCielo is far from a legitimate business, calling it a “self-enrichment” scheme.
"We believe PharmaCielo is nothing more than the latest self-enrichment scheme drummed up by its co-founder Anthony Wile, who had been charged by the SEC over allegations of securities fraud, stock promotion and market manipulation in the past,” Hindenburg said.
The company described the report as containing "numerous false and misleading statements" and said it's libelous.
“I would encourage all of our shareholders to exercise caution in relying on the blatant misrepresentations contained within the short seller report in question. This report was written with the express intention of manipulating market opinion, to reward a select group of short sellers at the expense of all honest market participants,” CEO David Attard said in the statement.
Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) submitted a Form 12b-25 with the U.S. Securities and Exchange Commission to postpone the date of filing its annual report.
MPX International Corporation (OTC:MPXOF) (CSE:MPXI) released first-quarter financial results, with net revenue of CA$616,309 ($460,869) versus revenue of CA$256,572 in the same period in the prior year.
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) hired current CFO Paolo De Luca as its chief strategy officer, and Derrick West, a member of the company's board of directors, as CFO.
YVY Life Sciences, a cannabis wellness company based in Uruguay, announced a oversubscribed $1.5 million seed round led by Facundo Garreton, who joins the team as a strategic partner. The round includes smaller investments from a number of strategic advisors, and leaders from other industries such as technology, pharma, wellness and food and beverages.